Questcor (QCOR +8.3%) gets a bump up from an upgrade to Buy at Suntrust this morning. The firm...

|By:, SA News Editor

Questcor (QCOR +8.3%) gets a bump up from an upgrade to Buy at Suntrust this morning. The firm notes that revenue from its nephrotic syndrome treatment is running far better than expected, and with new additions to its sales team it should easily Street script estimates.